Global Fertility Treatments Market Comprehensive Study: Forecasted Market Size And Growth Rate | Apollo Hospitals Enterprise Ltd., Care Fertility Group Limited, Genea Limited, Johns Hopkins Health System Corp., Medicover AB, Monash IVF Group, Progyny Inc.

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Fertility Treatments Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The fertility treatments market size has grown strongly in recent years. It will grow from $16.54 billion in 2023 to $17.97 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing infertility rates, advancements in reproductive medicine, healthcare coverage, awareness and stigma reduction.

The fertility treatments market size is expected to see strong growth in the next few years. It will grow to $25.02 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to delayed childbearing, expanding reproductive services, technological advancements, access to fertility services. Major trends in the forecast period include in vitro fertilization (ivf) advancements, single embryo transfer (set), telehealth and virtual consultations, fertility preservation for cancer patients.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=2811&type=smp

Market Segmentation:
The main product types of fertility are reagents, and equipment. A reagent is a material or compound that is added to a system to produce a chemical reaction or to determine whether or not a reaction occurred. The treatments are performed on female and male in fertility clinics, hospitals, surgical centers, and clinical research institutes.

Major Driver - Rising Fertility Treatments Demand Is The Changing Landscape Of Motherhood
The growth in the median age of first-time motherhood combined with change in lifestyle increased the difficulty of conceiving, increasing the demand for fertility treatment. The median age of first-time motherhood has increased all over the globe due to late marriages, contraceptive techniques, and an increase in the number of women who prioritize their careers over starting a family. In 2021 the average age of first-time mothers in America has risen from 25.6 in 2011 to 27.3 in 2021 . Women in other developed countries are also deferring, with the typical first birth occurring at the age of 31 for new mothers. In this scenario, a growing number of women are opting for IVF treatments, which is expected to drive the fertility treatments market.

Competitive Landscape:
Major companies operating in the fertility treatments market include Apollo Hospitals Enterprise Ltd., Care Fertility Group Limited, Genea Limited, Johns Hopkins Health System Corp., Medicover AB, Monash IVF Group, Progyny Inc., Vitrolife AB, Carolinas Fertility Institute PLLC, OvaScience Inc., Xytex Cryo International Ltd., Merck Group, Cook Group Incorporated, CooperSurgical Inc., Instituto Bernabeu, INVO Bioscience Inc., Cooper Companies Inc., Virtus Health Ltd., CryoChoice LLC, Millendo Therapeutics Inc., FUJIFILM Irvine Scientific Inc., LABOTECT GMBH, Fertility Focus Limited, Olympus Corporation, Irvine Scientific sales Company Inc., Ferring Pharmaceuticals Inc., Prelude Fertility Inc., Boston IVF, RMA Fertility Clinics, Shady Grove Fertility, CCRM Management Company LLC, IVIRMA Global, CARE Fertility

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Top Trend - Innovative Fertility Solutions To Drive The Revenues In The Market
Development of new techniques to treat infertility using a human's body is a key trend in the fertility treatments market. INVOcell is an IVF alternative that uses the woman's body to support fertilization, thus eliminating the cost of a laboratory incubator. The INVOcell device is placed with the eggs and sperm in the vaginal cavity, allowing for the stability of the natural environment, pH, and gas to help in fertilization. INVOcell, which is made in Medford, Massachusetts by INVO Bioscience, costs around $6,800 including medication. Although IVF generated more quality embryos, the birth rates between IVF and INVOcell are similar. According to the journal of assisted reproduction and genetics, 12 out of 20 women gave birth to 15 babies in IVF including three sets of twins and 11 out of 20 women gave birth to 16 babies in INVOcell group including five sets of twins.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Fertility Treatments Market Characteristics
3. Fertility Treatments Market Trends And Strategies
4. Fertility Treatments Market - Macro Economic Scenario
5. Fertility Treatments Market Size And Growth
…..
27. Fertility Treatments Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.